Platelet and neutrophil distributions in pump oxygenator circuits .3. Influence of nitric oxide gas infusion

被引:11
作者
Sly, MK
Prager, MD
Li, J
Harris, FB
Shastri, P
Bhujle, R
Chao, R
Kulkarni, PV
Constantinescu, A
Jessen, ME
Eberhart, RC
机构
[1] UNIV TEXAS,SW MED CTR,DEPT SURG,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT RADIOL,DALLAS,TX 75235
关键词
D O I
10.1097/00002480-199609000-00036
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The authors used quantitative gamma scintigraphy to evaluate the influence of nitric oxide gas on platelet and neutrophil deposition in Cobe Duo microporous oxygenators during cardiopulmonary bypass (CPB). The effects of nitric oxide gas on circulating platelet and neutrophil counts and platelet function also were assessed. Animals were prepared by standard methods. Cells were harvested, labeled ((111)ln platelet and Tc-99m neutrophil), infused, and recirculated. Nitric oxide gas, a guanylate cyclase pathway promoter, was infused in the Duo gas port at 500 ppm (t = 0-60 min), increased to 1,000 (t = 60-80 min), and stopped (final, 10 min). Images were taken at 10-15 min intervals during CPB. Standard isotope image corrections were made. No differences between nitric oxide gas and control experiments were observed for flow, pressure, hematocrit, or replacement volume. Nitric oxide gas infusion significantly (p < 0.05) reduced both platelet adherence to the oxygenator and in vitro platelet aggregation. Neutrophil adhesion tended to be lower, and circulating platelet and neutrophil counts tended to be higher with nitric oxide gas infusion. Results of in vitro aggregometry studies using rabbit platelets indicate that the class V phosphodiesterase inhibitor zaprinast can strongly enhance the inhibitory effects of nitric oxide. The authors conclude nitric oxide gas is a promising platelet sparing agent in the setting of CPB.
引用
收藏
页码:M494 / M499
页数:6
相关论文
共 16 条
[1]   INTERACTIONS BETWEEN ISOPRENALINE, SODIUM-NITROPRUSSIDE, AND ISOZYME-SELECTIVE PHOSPHODIESTERASE INHIBITORS ON ADP-INDUCED AGGREGATION AND CYCLIC-NUCLEOTIDE LEVELS IN HUMAN PLATELETS [J].
ANDERSSON, TLG ;
VINGE, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (02) :237-242
[2]   ACUTE RENAL-FAILURE FOLLOWING CARDIOPULMONARY BYPASS IN CHILDREN - RESULTS OF TREATMENT [J].
BAXTER, P ;
RIGBY, ML ;
JONES, ODH ;
LINCOLN, C ;
SHINEBOURNE, EA .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1985, 7 (03) :235-239
[3]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155
[4]  
BICK R L, 1976, Seminars in Thrombosis and Hemostasis, V3, P59
[5]  
COLLINS JD, 1983, LANCET, V1, P1119
[6]   OXIDATION OF NITROGEN-OXIDES BY BOUND DIOXYGEN IN HEMOPROTEINS [J].
DOYLE, MP ;
HOEKSTRA, JW .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1981, 14 (04) :351-358
[7]  
FANTA CH, 1992, EMERGEN MED, P118
[8]   ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE [J].
IGNARRO, LJ ;
BUGA, GM ;
WOOD, KS ;
BYRNS, RE ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9265-9269
[9]  
JESSEN M, 1995, ASAIO J S, V41, P63
[10]  
KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23